Acute Hepatic Injury Associated with Acute Administration of Synthetic Cannabinoid XLR-11 in Mouse Animal Model

The widespread recreational use of synthetic cannabinoids (SCs) has become a serious health issue. Reports of life-threatening intoxications related to SC consumption have markedly increased in recent years, including neurotoxicity, cardiotoxicity, nephrotoxicity, and hepatotoxicity. We investigated the impact of acute administration of the synthetic cannabinoid XLR-11 (3 mg/kg, i.p. for 5 consecutive days) on the liver in BALB/c mouse animal model. Using real-time quantitative RT-PCR, MDA assay, and TUNEL assay, we found consistent up-regulation of a variety of genes involved in oxidative stress (NOX2, NOX4, and iNOS), inflammation (TNF-α, IL-1β, IL-6), and apoptosis (Bax) in the liver of XLR-11 treated mice compared to control mice. These finding were supported with an elevation of MDA levels and TUNEL positive cells in the liver of XLR-11 treated mice which further confirm increased oxidative stress and apoptosis, respectively. Histopathological analysis of the liver of XLR-11 treated mice confirmed pronounced hepatic necrosis associated with inflammatory cell infiltration. Furthermore, elevated ALT and AST serum levels were also identified in XLR-11 treated mice indicating possible liver damage. Overall, SC-induced hepatotoxicity seems to be mainly mediated by activated oxidative stress and inflammatory processes in the liver, but the specific mechanisms involved require further investigations. However, the present study shed light on the potential deleterious role of acute administration of SCs in the progression to acute hepatic injury which enhances our understanding of the adverse effect of SC consumption.

[1]  Qing-Rong Liu,et al.  Hepatocyte cannabinoid 1 receptor nullification alleviates toxin-induced liver damage via NF-κB signaling , 2020, Cell Death & Disease.

[2]  A. Koçyiğit,et al.  Investigation of DNA damage, oxidative stress, and inflammation in synthetic cannabinoid users , 2020, Human & experimental toxicology.

[3]  G. Özhan,et al.  Inflammation and oxidative stress are key mediators in AKB48-induced neurotoxicity in vitro. , 2019, Toxicology in vitro : an international journal published in association with BIBRA.

[4]  M. A. Zaman,et al.  Acute Liver Injury Induced by Synthetic Cannabinoid Abuse , 2018, Cureus.

[5]  T. Roušar,et al.  An overview of apoptosis assays detecting DNA fragmentation , 2018, Molecular Biology Reports.

[6]  F. Carvalho,et al.  The synthetic cannabinoid XLR-11 induces in vitro nephrotoxicity by impairment of endocannabinoid-mediated regulation of mitochondrial function homeostasis and triggering of apoptosis. , 2018, Toxicology letters.

[7]  J. Ladero,et al.  Liver fibrosis. , 2018, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[8]  P. Jordan,et al.  Synthetic Cannabinoid Abuse and a Rare Alpha-1-Antitrypsin Mutant Causing Acute Fulminant Hepatitis: A Case Report and Review of the Literature , 2017, Case reports in hepatology.

[9]  G. Martinotti,et al.  Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset. , 2017, CNS & neurological disorders drug targets.

[10]  U. Lindequist,et al.  Mitochondrial functions of THP-1 monocytes following the exposure to selected natural compounds. , 2017, Toxicology.

[11]  S. Ricci,et al.  Hepatotoxicity associated to synthetic cannabinoids use. , 2017, European review for medical and pharmacological sciences.

[12]  W. Fantegrossi,et al.  Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites. , 2017, Current topics in behavioral neurosciences.

[13]  A. Mehari,et al.  Synthetic Marijuana-Induced Acute Liver Failure: 1820 , 2016 .

[14]  Qing-Rong Liu,et al.  Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism , 2016, Scientific Reports.

[15]  L. Olsen,et al.  Cytochrome P450-mediated metabolism of the synthetic cannabinoids UR-144 and XLR-11. , 2016, Drug testing and analysis.

[16]  V. Angerer,et al.  Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4 , 2016, Archives of Toxicology.

[17]  D. Mountain,et al.  A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment , 2016, Clinical toxicology.

[18]  A. Haslberger,et al.  Impact of a synthetic cannabinoid (CP-47,497-C8) on protein expression in human cells: evidence for induction of inflammation and DNA damage , 2016, Archives of Toxicology.

[19]  G. Behonick,et al.  Case reports of synthetic cannabinoid XLR-11 associated fatalities. , 2015, Forensic science international.

[20]  R. Law,et al.  Increase in Reported Adverse Health Effects Related to Synthetic Cannabinoid Use — United States, January–May 2015 , 2015, MMWR. Morbidity and mortality weekly report.

[21]  Shane M. Wilkinson,et al.  Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135. , 2015, ACS chemical neuroscience.

[22]  S. Hudson,et al.  Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues , 2015, Human & experimental toxicology.

[23]  K. Kuwayama,et al.  Detection of main metabolites of XLR-11 and its thermal degradation product in human hepatoma HepaRG cells and human urine. , 2015, Drug testing and analysis.

[24]  C. Marescaux,et al.  Tetrahydrocannabinol Induces Brain Mitochondrial Respiratory Chain Dysfunction and Increases Oxidative Stress: A Potential Mechanism Involved in Cannabis-Related Stroke , 2015, BioMed research international.

[25]  Bishow Paudel,et al.  Synthetic cannabinoids: the multi-organ failure and metabolic derangements associated with getting high , 2015, Journal of community hospital internal medicine perspectives.

[26]  H. Yoo,et al.  Determination of urinary metabolites of XLR-11 by liquid chromatography–quadrupole time-of-flight mass spectrometry , 2015, Analytical and Bioanalytical Chemistry.

[27]  M. Lukšič,et al.  SPICE/K2 Synthetic Marijuana-Induced Toxic Hepatitis Treated with N-Acetylcysteine , 2014, The American journal of case reports.

[28]  Marilyn A Huestis,et al.  Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. , 2014, Drug and alcohol dependence.

[29]  B. Thomas,et al.  Cannabinoids in disguise: Δ9-Tetrahydrocannabinol-like effects of tetramethylcyclopropyl ketone indoles , 2013, Neuropharmacology.

[30]  Marilyn A Huestis,et al.  First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry. , 2013, Clinical chemistry.

[31]  Y. Zou,et al.  PKC&bgr; Promotes Vascular Inflammation and Acceleration of Atherosclerosis in Diabetic ApoE Null Mice , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[32]  N. Teixeira,et al.  Endogenous cannabinoids revisited: a biochemistry perspective. , 2013, Prostaglandins & other lipid mediators.

[33]  G. Zlabinger,et al.  Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB1 , 2013, Archives of Toxicology.

[34]  P. Hollenberg,et al.  Cytochrome P450-Mediated Oxidative Metabolism of Abused Synthetic Cannabinoids Found in K2/Spice: Identification of Novel Cannabinoid Receptor Ligands , 2012, Drug Metabolism and Disposition.

[35]  K. Heard,et al.  A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. , 2012, Annals of emergency medicine.

[36]  T. Prisinzano,et al.  Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. , 2012, Biochemical pharmacology.

[37]  W. Fratta,et al.  Beyond THC: The New Generation of Cannabinoid Designer Drugs , 2011, Front. Behav. Neurosci..

[38]  William E. Fantegrossi,et al.  Phase I Hydroxylated Metabolites of the K2 Synthetic Cannabinoid JWH-018 Retain In Vitro and In Vivo Cannabinoid 1 Receptor Affinity and Activity , 2011, PloS one.

[39]  B. Aggarwal,et al.  Oxidative stress, inflammation, and cancer: how are they linked? , 2010, Free radical biology & medicine.

[40]  R. Flisiak,et al.  Role of cannabinoids in chronic liver diseases. , 2008, World journal of gastroenterology.

[41]  Liying Li,et al.  Antifibrogenic role of the cannabinoid receptor CB2 in the liver. , 2005, Gastroenterology.

[42]  R. Hampson,et al.  Cannabinoid physiology and pharmacology: 30 years of progress , 2004, Neuropharmacology.

[43]  A. Tarakhovsky,et al.  PKCβ modulates antigen receptor signaling via regulation of Btk membrane localization , 2001, The EMBO journal.

[44]  A. Makriyannis,et al.  Functional CB1 cannabinoid receptors in human vascular endothelial cells. , 2000, The Biochemical journal.

[45]  F. Cuccurullo,et al.  TBA test and "free" MDA assay in evaluation of lipid peroxidation and oxidative stress in tissue systems. , 1993, The American journal of physiology.

[46]  S. Aust,et al.  Microsomal lipid peroxidation. , 1978, Methods in enzymology.